Metabolic Syndrome x
Conditions
Brief summary
The objective is to evaluate therapeutic efficacy of 2 grams nano-phytosterols daily supplemention on diagnosis criteria of metabolic syndrome.
Interventions
DIETARY_SUPPLEMENTPhytosterols
Oral daily consumption of 2 grams of phytosterols (8 ml) per 180 days.
DIETARY_SUPPLEMENTTitanium Dioxide
Oral daily consumption of Titanium Dioxide (8 ml) per 180 days.
Sponsors
Universidad de los Andes, Chile
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Informed consent written * Available subjects to follow-up visits * Subjects with diagnoses of metabolic syndrome 5 years ago or with current diagnoses criteria * Subjects with health visits ongoing * Subjects with arterial hypertension under control. * Subjects with mellitus diabetes under control.
Exclusion criteria
* Subjects with alcoholism history. * Subjects with history of sitosterolemia. * Subjects with familiar hypercholesterolemia * Subjects who are consuming phytosterols * Pregnancy women * Breastfeeding period women * Subjects with personal history of: acute miocardical infarction, stroke, hypertensive emergency, acute or chronic diabetes descompensation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of proportion between study groups in the proportion of metabolic syndrome from baseline and the last visit (180 days). | 180 days |
Countries
Chile
Outcome results
None listed